$RGC @RegencellBio CEO Shares His Vision, Insights
Post# of 25453
(Total Views: 185)
Posted On: 09/29/2022 1:00:24 PM
$RGC @RegencellBio CEO Shares His Vision, Insights And Aims To Change The Way Patients Are Treated
Market sentiment has been relatively bearish over the last couple of months, as the ongoing health crisis and political tension has pushed market and economic performance to the brink of a looming recession. On top of this, rampant inflation, which has hit another 40-year high, and the Federal Reserve hiking interest rates have become, according to some experts, a recipe for an economic downturn.
Despite all these financial challenges, some industries have been looking to attract investors through progressive tactics as companies grow their influence and dominance in their respective markets.
Many investors, who are willing to risk some of their portfolio shares to help stabilize their position in the event of a recession, have placed major bets on the biotechnology and bioscience industry in recent months. According to a 2022 Mckinsey research report, biotech companies were able to raise more than $34 billion globally in 2021, doubling the $16 billion raised in 2020. https://www.ibtimes.com/regencell-ceo-shares-...ed-3600337
Market sentiment has been relatively bearish over the last couple of months, as the ongoing health crisis and political tension has pushed market and economic performance to the brink of a looming recession. On top of this, rampant inflation, which has hit another 40-year high, and the Federal Reserve hiking interest rates have become, according to some experts, a recipe for an economic downturn.
Despite all these financial challenges, some industries have been looking to attract investors through progressive tactics as companies grow their influence and dominance in their respective markets.
Many investors, who are willing to risk some of their portfolio shares to help stabilize their position in the event of a recession, have placed major bets on the biotechnology and bioscience industry in recent months. According to a 2022 Mckinsey research report, biotech companies were able to raise more than $34 billion globally in 2021, doubling the $16 billion raised in 2020. https://www.ibtimes.com/regencell-ceo-shares-...ed-3600337
(0)
(0)